Immunome Inc
IMNM
NASDAQ
Biotechnology
$27.20
USD
+0.78 (+2.95%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.00B
Volume 759.6K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
IDYA | IDEAYA Biosciences Inc | $3.55B | - | +3118.1% | - | |
CLDX | Celldex Therapeutics Inc | $3.39B | - | -97.3% | - | |
ARQT | Arcutis Biotherapeutics Inc | $3.25B | 113.86 | +76.1% | - | |
IRON | Disc Medicine Inc | $3.07B | - | - | - | |
GRAL | Grail Inc | $3.05B | - | +23.1% | - | |
IMNM | Immunome Inc | $3.00B | - | -63.3% | - | |
IOVA | Iovance Biotherapeutics Inc | $2.98B | - | +34.5% | - | |
NRIX | Nurix Therapeutics Inc | $2.79B | - | -58.4% | - | |
BEAM | Beam Therapeutics Inc | $2.73B | - | +158.9% | - |
Top Peer by Growth
IDEAYA Biosciences Inc
+3118.1% YoY Revenue
Lowest P/E Ratio
Arcutis Biotherapeutics Inc
113.86x P/E
Best 1-Year Return
Immunome Inc
+182.4% Return